Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 December 2000:
Vol. 290. no. 5498, pp. 1870 - 1871
DOI: 10.1126/science.290.5498.1870b
Prev | Table of Contents | Next

News of the Week

HEPATITIS C:
New 'Replicon' Yields Viral Proteins

Eliot Marshall

Efforts to determine just how hepatitis C infection develops-and how to combat it with antiviral drugs-have been frustrated by the hepatitis C virus's (HCV's) stubborn refusal to grow in the laboratory. Now, a research team has partly overcome that problem: On page 1972 of this issue, the researchers report the creation of an improved viruslike "replicon" that produces HCV proteins efficiently in the lab. The innovation has piqued the interest of both industrial and academic scientists, who are racing to develop treatments.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)